Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | President | March 05, 2019 | March 07, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date March 05, 2019 · Filed March 07, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-03-07 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2019-03-05 · Exercise / conversion · Acquired 89,583 · Balance 89,583 Row 2 · 2019-03-05 · Exercise / conversion · Acquired 47,500 · Balance 137,083 Row 3 · 2019-03-05 · Exercise / conversion · Acquired 20,454 · Balance 157,537 Row 4 · 2019-03-05 · Exercise / conversion · Acquired 8,333 · Balance 165,870 Row 5 · 2019-03-05 · Sale · Disposed 165,870 · Balance 0 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.80 to $47.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Row 6 · 2019-03-06 · Exercise / conversion · Acquired 2,879 · Balance 2,879 Row 7 · 2019-03-06 · Exercise / conversion · Acquired 5,507 · Balance 8,386 Row 8 · 2019-03-06 · Sale · Disposed 8,386 · Balance 0 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Row 9 · 2019-03-07 · Exercise / conversion · Acquired 37,826 · Balance 37,826 Row 10 · 2019-03-07 · Sale · Disposed 37,826 · Balance 0 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $25.65 · Expires 2025-07-07 | Direct | 10,417 |
Reported balance
After 2019-03-05 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-03-05 · Exercise / conversion · Disposed 89,583 · Balance 10,417 F4: These options were granted on July 7, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 7, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $25.52 · Expires 2026-01-25 | Direct | 12,500 |
Reported balance
After 2019-03-05 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2019-03-05 · Exercise / conversion · Disposed 47,500 · Balance 12,500 F5: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $43.77 · Expires 2028-01-22 | Direct | 59,546 |
Reported balance
After 2019-03-05 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2019-03-05 · Exercise / conversion · Disposed 20,454 · Balance 59,546 F6: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $24.10 · Expires 2025-01-20 | Direct | 0 |
Reported balance
After 2019-03-05 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2019-03-05 · Exercise / conversion · Disposed 8,333 · Balance 0 F7: These options were granted on January 20, 2015, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $43.77 · Expires 2028-01-22 | Direct | 56,667 |
Reported balance
After 2019-03-06 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2019-03-06 · Exercise / conversion · Disposed 2,879 · Balance 56,667 F6: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $26.27 · Expires 2027-01-30 | Direct | 74,493 |
Reported balance
After 2019-03-06 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2019-03-06 · Exercise / conversion · Disposed 5,507 · Balance 74,493 F8: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $26.27 · Expires 2027-01-30 | Direct | 36,667 |
Reported balance
After 2019-03-07 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2019-03-07 · Exercise / conversion · Disposed 37,826 · Balance 36,667 F8: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.80 to $47.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4: These options were granted on July 7, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 7, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F5: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F6: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F7: These options were granted on January 20, 2015, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F8: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 37,826 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 17 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,667 Underlying: Class A Common Stock · 37,826 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 07, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 37,826 | $46.01 | $1,740,374.26 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 10 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| March 07, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 37,826 | $26.27 | $993,689.02 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 9 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,507 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 16 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,493 Underlying: Class A Common Stock · 5,507 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 2,879 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 15 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,667 Underlying: Class A Common Stock · 2,879 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 8,386 | $46.14 | $386,930.04 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 8 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,507 | $26.27 | $144,668.89 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 7 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 2,879 | $43.77 | $126,013.83 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 6 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 8,333 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 14 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 8,333 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on January 20, 2015, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 20,454 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 13 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,546 Underlying: Class A Common Stock · 20,454 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 47,500 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 12 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Class A Common Stock · 47,500 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 89,583 | $0.00 Strike: $25.65 | $0.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · derivative · entry 11 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,417 Underlying: Class A Common Stock · 89,583 shares Expires 2025-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on July 7, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 7, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 165,870 | $47.05 | $7,804,183.50 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 5 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.80 to $47.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 8,333 | $24.10 | $200,825.30 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 4 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 20,454 | $43.77 | $895,271.58 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 3 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 47,500 | $25.52 | $1,212,200.00 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 2 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 89,583 | $25.65 | $2,297,803.95 |
DisclosureSEC source: 0001209191-19-017822 · doc4.xml · nonDerivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2019 Filed Feb 11, 2019 21:34 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 80,000 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0001209191-19-008948 · doc4.xml · derivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2029-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 41,667 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · derivative · entry 10 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Class A Common Stock · 41,667 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · derivative · entry 9 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 40,000 shares Expires 2024-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on June 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · derivative · entry 8 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,000 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 10,000 | $0.00 Strike: $13.04 | $0.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · derivative · entry 7 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 1,400 | $56.87 | $79,620.80 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · nonDerivative · entry 6 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.835 to $56.925, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 120,267 | $56.14 | $6,751,224.13 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · nonDerivative · entry 5 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.83 to $56.74, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 41,667 | $24.10 | $1,004,174.70 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · nonDerivative · entry 4 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 40,000 | $24.42 | $976,800.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · nonDerivative · entry 3 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 30,000 | $23.95 | $718,500.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · nonDerivative · entry 2 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 20:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 10,000 | $13.04 | $130,400.00 |
DisclosureSEC source: 0001209191-18-037434 · doc4.xml · nonDerivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 21:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 80,000 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-18-005090 · doc4.xml · derivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2028-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 21:13 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $13.04 | $0.00 |
DisclosureSEC source: 0001209191-17-065674 · doc4.xml · derivative · entry 3 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 15,000 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 21:13 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 15,000 | $38.30 | $574,491.00 |
DisclosureSEC source: 0001209191-17-065674 · doc4.xml · nonDerivative · entry 2 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on November 13, 2017, which is intended to comply with Rule 10b5-1. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.01 to $38.60, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 21:13 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 15,000 | $13.04 | $195,600.00 |
DisclosureSEC source: 0001209191-17-065674 · doc4.xml · nonDerivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 16,153 | $0.00 Strike: $11.28 | $0.00 |
DisclosureSEC source: 0001209191-17-038100 · doc4.xml · derivative · entry 3 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 16,153 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 20, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on March 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 16,153 | $31.94 | $515,942.97 |
DisclosureSEC source: 0001209191-17-038100 · doc4.xml · nonDerivative · entry 2 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on May 5, 2017, which is intended to comply with Rule 10b5-1. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.78 to $32.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 16,153 | $11.28 | $182,205.84 |
DisclosureSEC source: 0001209191-17-038100 · doc4.xml · nonDerivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 80,000 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-17-006655 · doc4.xml · derivative · entry 1 Williams Anthony L · CIK 0001635534 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.